Publications in collaboration with researchers from Yale School of Medicine (6)

2024

  1. Baricitinib Withdrawal and Retreatment in Patients with Severe Alopecia Areata: The BRAVE-AA1 Randomized Clinical Trial

    JAMA Dermatology, Vol. 160, Núm. 10, pp. 1075-1081

  2. Correction to: Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib (Dermatology and Therapy, (2024), 14, 7, (1959-1968), 10.1007/s13555-024-01208-x)

    Dermatology and Therapy

  3. Improvement in Measures of Quality of Life and Symptoms of Anxiety and Depression in Patients with Severe Alopecia Areata Achieving Sustained Scalp Hair Regrowth with Baricitinib

    Dermatology and Therapy, Vol. 14, Núm. 7, pp. 1959-1968

  4. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results from a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity

    JAMA Dermatology, Vol. 160, Núm. 3, pp. 341-350

  5. Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial

    JEADV Clinical Practice, Vol. 3, Núm. 2, pp. 528-535

2021

  1. A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)

    JAMA Dermatology, Vol. 157, Núm. 4, pp. 439-448